Anticoagulation Reversal and Treatment Strategies in Major Bleeding: Update 2016.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. An Overview of Anticoagulant Drugs Pharmacology, Therapeutic Approaches, Limitations and Perspectives.Pharmaceutics · 2026
   Review
2. Interventions for reducing red blood cell transfusion in adults undergoing hip fracture surgery: an overview of systematic reviews.The Cochrane database of systematic reviews · 2023
   Review
3. Hibernation and hemostasis.Frontiers in physiology · 2023
   Review
4. Direct oral anticoagulants: A review for the non-specialist.Hematology reports · 2021
   Article
5. Antidotes for childhood toxidromes.Drugs in context · 2021
   Review
6. Potent and rapid reversal of the von Willebrand factor inhibitor aptamer BT200.Journal of thrombosis and haemostasis : JTH · 2020
   Article
7. Direct-Acting Oral Anticoagulants and Their Reversal Agents-An Update.Medicines (Basel, Switzerland) · 2019
   Review
8. Update on Management of Portal Vein Thrombosis and the Role of Novel Anticoagulants.Journal of clinical and translational hepatology · 2019
   Review
9. Approach to the Diagnosis and Management of Subarachnoid Hemorrhage.The western journal of emergency medicine · 2019
   Review
10. Comparative effectiveness of rivaroxaban in the treatment of nonvalvular atrial fibrillation.Journal of comparative effectiveness research · 2017
    Review
11. Exploring indications for the Use of direct oral anticoagulants and the associated risks of major bleeding.The American journal of managed care · 2017
    Article

Corrections and comments

• Erratum issued
  Erratum: This Article Corrects: "Anticoagulation Reversal and Treatment Strategies in Major Bleeding: Update 2016".2016

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as